Annual Report 2010/11 - Sonova

Annual Report 2010/11 - Sonova Annual Report 2010/11 - Sonova

02.12.2012 Views

154 Executive Equity Award Plan The Executive Equity Award Plan (EEAP) serves as a long-term incentive and is offered annually to the Board of Directors, the management Board, as well as other management levels of the Sonova Group. A total of approximately 400 people are participating in the 2011 plan. The plan entitles them to receive shares, options, warrants, warrant appreciation rights (WARs), and/or restricted share units (RSUs). The number of shares, options, warrants, WARs, and RSUs granted varies depending on the respective management level and on individual performance. The shares, options, warrants, WARs, and RSUs granted as part of the EEAP are split into four equal tranches. The options, warrants and WARs have terms of five years. Each tranche vests each year, starting one year after the grant date. The strike price on which the options, warrants and WARs are based corresponds to the closing price for the shares on the Swiss stock exchange (SIX Swiss Exchange) on the date on which the options, warrants, and WARs were granted. The fair value of the options, warrants and WARs is calculated on the grant date using an option pricing model. The shares/RSUs have a blocking period of up to four years. One of the four equal tranches vests each year, starting one year after the grant date. Additional information can be found in Note 30 to the consolidated financial statements. Determination of the compensation to members of the Board of Directors The compensation policies for the Board of Directors differ from those for Sonova Group employees. The members of the Board of Directors receive a retainer and no variable cash compensation. The members of the Board of Directors also participate in the Executive Equity Award Plan. The compensation for the members of the Board of Directors is defined by the Nomination and Compensation Committee, periodically reviewed and set by the Board of Directors. Determination of the compensation to members of the management Board The compensation policies and the Executive Equity Award Plan (EEAP) described above apply to the CEO and the management Board. In management Board compensation, the variable salary component has a stronger weighting with respect to the target income than for other employees of the Sonova Group. The variable cash compensation varies between 30%–40% of the target salary for members of the management Board and 50% of the target salary for the former CEO. If a member of the management Board achieves less than 80% of the stipulated target, no variable salary component is paid out. If the target is exceeded, the variable cash compensation may be granted to a maximum of double the original amount, or for the former CEO, a maximum of 174%, depending on the actual level of achievement. The variable cash compensation is a function of company performance, based on sales, operating profit (EBITA) and individual achievement of objectives. The sales and EBITA targets are not interlinked. The Board of Directors can also award further cash components for exceptional achievements that do not fall under the annual objectives. The former CEO’s incentive plan differed in that the EEAP options were not granted to the former CEO annually in the last few years. The granting of options, including the period for exercising, was part of his employment contract.

COmPENSATION TO mEmBERS OF THE BOARD OF DIRECTORS AND THE mANAGEmENT BOARD FINANCIAL STATEmENTS OF SONOVA HOLDING AG 155 Compensation to the Board of Directors Total compensation to the Board of Directors consists of a fixed fee, attendance fees, expenses, social benefits (employer’s contribution), and participation in the Executive Equity Award Plan (solely with entitlement to receive options, warrants, WARs, and SARs). The following table shows the compensation of the individual members of the Board of Directors in the year under review and in the previous year: in CHF 2010/11 Fixed fee Attendance fee/expenses 1) Social benefits (employer’s contribution) 2) Total cash compensation Value of warrants 3) Number of warrants 3) granted Total compensation Robert F. Spoerry, Chairman4) 120,000 27,500 152,806 300,306 240,300 250,000 540,606 William D. Dearstyne, Vice-Chairman 120,000 30,000 320,122 470,122 240,300 250,0005) 710,422 Andy Rihs, member4) 120,000 31,000 188,790 339,790 240,300 250,000 580,090 Heliane Canepa, member 120,000 27,000 61,484 208,484 240,300 250,000 448,784 Dr Michael Jacobi, member 120,000 23,500 63,758 207,258 240,300 250,000 447,558 Anssi Vanjoki, member 120,000 15,500 25,715 161,215 240,300 250,000 401,515 Ronald van der Vis, member 120,000 14,500 25,539 160,039 240,300 250,000 400,339 John J. Zei, member6) 90,000 16,500 17,713 124,213 240,300 250,0005) 364,513 Total 930,000 185,500 855,927 1,971,427 1,922,400 2,000,000 3,893,827 1) Attendance fees and expenses are based on the number of attended meetings of each member of the Board of Directors. 2) Including social security contributions on the tax value of options/WARs/SARs exercised during the reporting period. 3) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements). 4) Robert F. Spoerry took over the position as chairman of the Board of Directors from Andy Rihs in march 2011. 5) WARs (WARs grant the right to participate in the appreciation of the Sonova shares without issuance of shares). 6) New member of the Board of Directors since June 2010. Dr Valentin Chapero Rueda received no compensation for his mandate as a member of the Board of Directors due to his mandate as CEO. in CHF 2009/10 Fixed fee Attendance fee/expenses 1) Social benefits (employer’s contribution) 2) Total cash compensation Value of warrants 3) Number of warrants 3) granted Total compensation Andy Rihs, Chairman 120,000 28,000 146,705 294,705 275,725 250,000 570,430 William D. Dearstyne, Vice-Chairman 60,000 28,000 11,211 99,211 275,725 250,0004) 374,936 Heliane Canepa, member 60,000 23,000 98,225 181,225 275,725 250,000 456,950 Dr Michael Jacobi, member 60,000 24,500 259,414 343,914 275,725 250,000 619,639 Robert F. Spoerry, member 60,000 22,500 204,642 287,142 275,725 250,000 562,867 Anssi Vanjoki, member 45,000 12,500 10,456 67,956 275,725 250,000 343,681 Ronald van der Vis, member 45,000 12,000 10,456 67,456 275,725 250,000 343,181 Total 450,000 150,500 741,109 1,341,609 1,930,075 1,750,000 3,271,684 1) Attendance fees and expenses are based on the number of attended meetings of each member of the Board of Directors. 2) Including social security contributions on the tax value of options/WARs/SARs exercised during the reporting period. 3) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements). 4) WARs (WARs grant the right to participate in the appreciation of the Sonova shares without issuance of shares). Dr Valentin Chapero Rueda received no compensation for his mandate as a member of the Board of Directors due to his mandate as CEO.

COmPENSATION TO mEmBERS OF THE BOARD OF DIRECTORS AND THE mANAGEmENT BOARD<br />

FINANCIAL STATEmENTS OF SONOVA HOLDING AG 155<br />

Compensation to the Board of Directors<br />

Total compensation to the Board of Directors consists of a fixed fee, attendance fees, expenses, social benefits (employer’s<br />

contribution), and participation in the Executive Equity Award Plan (solely with entitlement to receive options, warrants,<br />

WARs, and SARs).<br />

The following table shows the compensation of the individual members of the Board of Directors in the year under review<br />

and in the previous year:<br />

in CHF <strong>2010</strong>/<strong>11</strong><br />

Fixed fee Attendance<br />

fee/expenses 1)<br />

Social benefits<br />

(employer’s<br />

contribution) 2)<br />

Total cash<br />

compensation<br />

Value of<br />

warrants 3)<br />

Number of<br />

warrants 3)<br />

granted<br />

Total<br />

compensation<br />

Robert F. Spoerry, Chairman4) 120,000 27,500 152,806 300,306 240,300 250,000 540,606<br />

William D. Dearstyne, Vice-Chairman 120,000 30,000 320,122 470,122 240,300 250,0005) 710,422<br />

Andy Rihs, member4) 120,000 31,000 188,790 339,790 240,300 250,000 580,090<br />

Heliane Canepa, member 120,000 27,000 61,484 208,484 240,300 250,000 448,784<br />

Dr Michael Jacobi, member 120,000 23,500 63,758 207,258 240,300 250,000 447,558<br />

Anssi Vanjoki, member 120,000 15,500 25,715 161,215 240,300 250,000 401,515<br />

Ronald van der Vis, member 120,000 14,500 25,539 160,039 240,300 250,000 400,339<br />

John J. Zei, member6) 90,000 16,500 17,713 124,213 240,300 250,0005) 364,513<br />

Total 930,000 185,500 855,927 1,971,427 1,922,400 2,000,000 3,893,827<br />

1) Attendance fees and expenses are based on the number of attended meetings of each member of the Board of Directors.<br />

2) Including social security contributions on the tax value of options/WARs/SARs exercised during the reporting period.<br />

3) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements).<br />

4) Robert F. Spoerry took over the position as chairman of the Board of Directors from Andy Rihs in march 20<strong>11</strong>.<br />

5) WARs (WARs grant the right to participate in the appreciation of the <strong>Sonova</strong> shares without issuance of shares).<br />

6) New member of the Board of Directors since June <strong>2010</strong>.<br />

Dr Valentin Chapero Rueda received no compensation for his mandate as a member of the Board of Directors due to his mandate as CEO.<br />

in CHF 2009/10<br />

Fixed fee Attendance<br />

fee/expenses 1)<br />

Social benefits<br />

(employer’s<br />

contribution) 2)<br />

Total cash<br />

compensation<br />

Value of<br />

warrants 3)<br />

Number of<br />

warrants 3)<br />

granted<br />

Total<br />

compensation<br />

Andy Rihs, Chairman 120,000 28,000 146,705 294,705 275,725 250,000 570,430<br />

William D. Dearstyne, Vice-Chairman 60,000 28,000 <strong>11</strong>,2<strong>11</strong> 99,2<strong>11</strong> 275,725 250,0004) 374,936<br />

Heliane Canepa, member 60,000 23,000 98,225 181,225 275,725 250,000 456,950<br />

Dr Michael Jacobi, member 60,000 24,500 259,414 343,914 275,725 250,000 619,639<br />

Robert F. Spoerry, member 60,000 22,500 204,642 287,142 275,725 250,000 562,867<br />

Anssi Vanjoki, member 45,000 12,500 10,456 67,956 275,725 250,000 343,681<br />

Ronald van der Vis, member 45,000 12,000 10,456 67,456 275,725 250,000 343,181<br />

Total 450,000 150,500 741,109 1,341,609 1,930,075 1,750,000 3,271,684<br />

1) Attendance fees and expenses are based on the number of attended meetings of each member of the Board of Directors.<br />

2) Including social security contributions on the tax value of options/WARs/SARs exercised during the reporting period.<br />

3) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements).<br />

4) WARs (WARs grant the right to participate in the appreciation of the <strong>Sonova</strong> shares without issuance of shares).<br />

Dr Valentin Chapero Rueda received no compensation for his mandate as a member of the Board of Directors due to his mandate as CEO.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!